Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

March 31, 2019

Conditions
Breast Cancer
Interventions
DRUG

Infracyanine

In the beginning of the intervention, a periareolar injection of the Infracyanine will be carried out (Infracyanine®, 2ml to 2.5mg/ml whether 3.2nM).

Trial Locations (1)

75015

Hôpital Européen Georges Pompidou, Paris

All Listed Sponsors
lead

Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie

OTHER

NCT02875626 - Role of Indocyanine Green (ICG) for Detection of Sentinel Nodes in Breast Cancer | Biotech Hunter | Biotech Hunter